Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02708589
Other study ID # 600
Secondary ID
Status Recruiting
Phase Phase 2/Phase 3
First received March 1, 2016
Last updated March 9, 2016
Start date September 2015

Study information

Verified date March 2016
Source National Nutrition and Food Technology Institute
Contact n/a
Is FDA regulated No
Health authority Iran: FDA
Study type Interventional

Clinical Trial Summary

In this study, patients undergoing the bariatric surgery will be assigned to take either probiotic capsules or placebos from 1 month before surgery to 3 months after the surgery. Their anthropometric and biochemical measurements will be assessed every 3-6 months, and will be compared in two groups.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date
Est. primary completion date September 2017
Accepts healthy volunteers No
Gender Both
Age group 14 Years to 70 Years
Eligibility Inclusion Criteria:

- BMI> 40 or >35 plus other morbidities

- Undergoing the gastric bypass surgery

- Willing to participate in the study

Exclusion Criteria:

- History of any chronic GI or kidney disorders, malignancies, or immune deficiencies

- Taking any immunomodulatory or immunosuppressor medications

- Taking Antibiotics from 4 weeks before and during the intervention

- Being on special diet such as vegetarian diet

- Doing as a professional Athlete

- Pregnancy and Lactation

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
probiotic

Other:
Placebo


Locations

Country Name City State
Iran, Islamic Republic of NNFTRI clinic Tehran

Sponsors (1)

Lead Sponsor Collaborator
National Nutrition and Food Technology Institute

Country where clinical trial is conducted

Iran, Islamic Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary weigh of the participants will be measured in Kg. 3 months after surgery No
Secondary serum level of vitamin B12 (mg/dl) 3 months after surgery No
Secondary serum level of vitamin B12 (mg/dl) 12 months after surgery No
Secondary serum level of vitamin D(ng/ml) 3 months after surgery No
Secondary serum level of vitamin D (ng/ml) 12 months after surgery No
See also
  Status Clinical Trial Phase
Recruiting NCT03046147 - The Effect of Roux-en-Y Gastric Bypass on Bone Turnover N/A
Completed NCT01938469 - Effect of Meal Number, Frequency, and Form on Satiety and Metabolism After Weight Loss Surgery N/A
Withdrawn NCT01930448 - Mechanisms of Diabetes Control After Weight Loss Surgery, Sub-study #1 N/A
Completed NCT00571220 - Mechanisms of Diabetes Control After Weight Loss Surgery N/A
Withdrawn NCT00863993 - Energy Expenditure and Gastric Bypass Surgery N/A
Completed NCT03402347 - Ex Vivo Evaluation of Laser Induced Thermal Tissue Damage N/A
Terminated NCT03201952 - Examination of the Metabolic Effects of Direct Bile Salt Delivery to the Ileum in Humans Phase 1